As a sponsor of the 21st Annual Meeting of the Oligonucleotide Therapeutics Society, Synoligo is eager to engage with the researchers and experts who are shaping the future of oligo therapeutics, including those working on antisense, siRNA, immunostimulatory, and aptamers. Stop by Booth#27 to learn how our services are designed to accelerate your process and help you advance your projects from discovery to pre-clinical studies with greater efficiency.
See our offerings: https://lnkd.in/gsuJkV4G